Paul K Wotton Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul K Wotton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul K Wotton. Paul K Wotton is Director in ANTARES PHARMA, INC. ($ATRS) and in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and President and CEO in Ocata Therapeutics, Inc. ($ACTC).
Latest Insider Trading Transactions of Paul K Wotton
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, ACTC, ASTM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 16.62 | 13,125 | 218,138 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 16.62 | 13,125 | 218,138 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 14.56 | 13,125 | 191,100 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 14.56 | 13,125 | 191,100 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 13.05 | 17,500 | 228,375 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 13.05 | 17,500 | 228,375 | 0 | ||
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 48.88 | 2,200 | 107,534 | 31,602 | 33.8 K to 31.6 K (-6.51 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 48.88 | 2,200 | 107,534 | 31,602 | 33.8 K to 31.6 K (-6.51 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 50.11 | 13,448 | 673,922 | 33,802 | 47.3 K to 33.8 K (-28.46 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 50.11 | 13,448 | 673,922 | 33,802 | 47.3 K to 33.8 K (-28.46 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 16.62 | 13,125 | 218,138 | 47,250 | 34.1 K to 47.3 K (+38.46 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 16.62 | 13,125 | 218,138 | 47,250 | 34.1 K to 47.3 K (+38.46 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 14.56 | 13,125 | 191,100 | 34,125 | 21 K to 34.1 K (+62.50 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 14.56 | 13,125 | 191,100 | 34,125 | 21 K to 34.1 K (+62.50 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 13.05 | 17,500 | 228,375 | 21,000 | 3.5 K to 21 K (+500.00 %) | |
May 13 2021 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 13.05 | 17,500 | 228,375 | 21,000 | 3.5 K to 21 K (+500.00 %) | |
May 01 2020 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | ||
May 01 2020 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 14.56 | 13,125 | 191,100 | 13,125 | ||
May 01 2020 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 0.00 | 1,750 | 0 | 0 | ||
May 01 2020 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 0.00 | 1,750 | 0 | 1,750 | 0 to 1.8 K | |
May 03 2019 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | ||
May 03 2019 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 16.62 | 13,125 | 218,138 | 13,125 | ||
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 3.74 | 15,000 | 56,100 | 0 | ||
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 2.76 | 10,000 | 27,600 | 5,000 | ||
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | M | 3.74 | 5,000 | 18,700 | 0 | ||
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 12.06 | 5,000 | 60,300 | 0 | 5 K to 0 (-100.00 %) | |
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 12.06 | 15,000 | 180,900 | 5,000 | 20 K to 5 K (-75.00 %) | |
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Sell | S | 12.06 | 10,000 | 120,600 | 20,000 | 30 K to 20 K (-33.33 %) | |
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 3.74 | 15,000 | 56,100 | 30,000 | 15 K to 30 K (+100.00 %) | |
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 2.76 | 10,000 | 27,600 | 15,000 | 5 K to 15 K (+200.00 %) | |
Jun 20 2018 | ASTM | Vericel Corp | Wotton Paul K | Buy | M | 3.74 | 5,000 | 18,700 | 5,000 | 0 to 5 K | |
May 03 2018 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 13.05 | 17,500 | 228,375 | 17,500 | ||
May 05 2017 | ASTM | Vericel Corp | Wotton Paul K | Option Exercise | A | 2.63 | 17,500 | 46,025 | 17,500 | ||
May 06 2016 | ASTM | Vericel Corp | Wotton Paul K | Director | Option Exercise | A | 2.76 | 15,000 | 41,400 | 15,000 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Option Exercise | D | 6.55 | 300,000 | 1,965,000 | 0 | |
Feb 11 2016 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Sell | U | 8.50 | 277,500 | 2,358,750 | 0 | 277.5 K to 0 (-100.00 %) |
Jul 31 2015 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Payment of Exercise | F | 4.23 | 32,500 | 137,475 | 267,500 | 300 K to 267.5 K (-10.83 %) |
Mar 24 2015 | ASTM | Vericel Corp | Wotton Paul K | Director | Option Exercise | A | 3.74 | 20,000 | 74,800 | 20,000 | |
Mar 09 2015 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 310,000 | 300 K to 310 K (+3.33 %) |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 27,500 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 2,500 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 0 |
Page: 1